Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-27

Clinical Trial Update: Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing Crecheck Tablet 2.5 mg rosuvastatin calcium with Crestor Tablet 5 mg rosuvastatin calcium in healthy adult subjects; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crecheck Tablet 2.5 mg (Rosuvastatin calcium)
  • Crestor Tablet 5 mg (Rosuvastatin calcium)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Primary Hypercholesterolemia, Combined Hyperlipidemia | Phase 1 | Status: COMPLETED